Black Katherine A, Galata Gabriele, Schulte Klaus-Martin, Hubbard Johnathan G
Department of Surgery, King's College Hospital, London, UK.
Gland Surg. 2023 Aug 30;12(8):1060-1066. doi: 10.21037/gs-23-54. Epub 2023 Aug 21.
Both subtotal parathyroidectomy (SPTX) and total parathyroidectomy with autotransplantation (TPTX + AT) are considered acceptable surgical approaches for renal patients. It is common that parathyroid surgery is performed in patients before they undergo kidney transplantation and there is currently no evidence considering the best surgical approach in this subset of patients.
Two cohorts were identified of consecutive patients who underwent parathyroidectomy for renal hyperparathyroidism by two surgeons at a single institution over equivalent time periods (SPTX and TPTX + AT). A retrospective chart review was performed to assess these techniques, including outcomes following kidney transplantation.
There were 125 patients analysed, with 56 patients who underwent SPTX and 69 who underwent TPTX + AT. Both cohorts effectively reduced PTH post operatively. There were 22 patients in the SPTX cohort and 26 in the TPTX + AT cohort that subsequently received kidney transplants. There were no cases of recurrent hyperparathyroidism and one of hypoparathyroidism (4.5%) in the SPTX patients post-transplant. There was one case of recurrent hyperparathyroidism (3.8%) and four of persistent hypoparathyroidism (15.4%) in the TPTX + AT patients post-transplant.
Surgery for renal hyperparathyroidism requires a careful balance of the extent of parathyroid resection to prevent persistent/recurrent disease and avoid permanent hypoparathyroidism. SPTX may be a more appropriate option in kidney transplant candidates in order to minimise the risk of long-term hypoparathyroidism.
甲状旁腺次全切除术(SPTX)和甲状旁腺全切除术加自体移植术(TPTX + AT)均被认为是适用于肾病患者的手术方法。甲状旁腺手术常在患者进行肾移植之前进行,目前尚无证据表明该类患者的最佳手术方法。
确定了两个队列,为在同一机构由两位外科医生在相同时间段内对肾性甲状旁腺功能亢进症患者进行甲状旁腺切除术的连续患者(SPTX和TPTX + AT)。进行回顾性病历审查以评估这些技术,包括肾移植后的结果。
共分析了125例患者,其中56例行SPTX,69例行TPTX + AT。两个队列术后均有效降低了甲状旁腺激素(PTH)水平。SPTX队列中有22例患者、TPTX + AT队列中有26例患者随后接受了肾移植。移植后,SPTX患者中无复发性甲状旁腺功能亢进病例,有1例甲状旁腺功能减退病例(4.5%)。TPTX + AT患者移植后有1例复发性甲状旁腺功能亢进病例(3.8%)和4例持续性甲状旁腺功能减退病例(15.4%)。
肾性甲状旁腺功能亢进症的手术需要仔细权衡甲状旁腺切除的范围,以预防持续性/复发性疾病并避免永久性甲状旁腺功能减退。对于肾移植候选者,SPTX可能是更合适的选择,以尽量降低长期甲状旁腺功能减退的风险。